ea0070aep748 | Pituitary and Neuroendocrinology | ECE2020
Coopmans Eva
, El-Sayed Nour
, Frystyk Jan
, Erik Magnusson Nils
, Otto Jorgensen Jens
, Jan Van der Lely Aart
, Janssen Joseph AM
, Muhammad Ammar
, Neggers Sebastian
Purpose: Although quality of life (QoL) is improved in patients with acromegaly after disease control, QoL correlates only weakly with traditional biomarkers. Our objective is to investigate a potential relation between the new serum biomarker soluble Klotho (sKlotho), GH and insulin-like growth factor 1 (IGF-1) levels and QoL.Methods: In this prospective cohort study, we investigated 54 acromegaly patients biochemically well-controlled on combination tr...